More than three-quarters dropped at least 5% of their weight, and around 30% lost 20% or more
If a caregiver assists, the upper arm can substitute for any week in the cycle
| BioPharma Dive, accessed February 2, 2026, Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices | AJMC, accessed February 2, 2026, Federal Update: Trump Administration Announces Deal to Bring Most-Favored-Nation Pricing to GLP-1s AMCP, accessed February 2, 2026, Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs, accessed February 2, 2026, The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth, accessed February 2, 2026, Eli Lilly Stock Outlook: Fast-Track Oral GLP-1 Review Meets Long-Term Catalysts, accessed February 2, 2026, Beyond the Needle: Eli Lillys Orforglipron and the Small Molecule GLP-1 Revolution, accessed February 2, 2026, Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (20202025): What the IP and Science Signal Next | Cypris, accessed February 2, 2026,
Lifting weights or performing bodyweight exercises sends a direct signal to muscles that they are needed, overriding the catabolic signals created by calorie restriction
Clinical eligibility does not translate to real-world access
Pros: $149/month, all-in, for compounded semaglutide No insurance required Simple enrollment and fast shipping No hidden fees Cons: Basic medical oversight No lab monitoring included No coaching or lifestyle support #2
